Zhitong Finance App News, Yingjixin (688209.SH) issued an announcement. On January 6, 2026, the company responded to investors' “brain-computer interface” issues on the Shanghai Stock Exchange E interactive platform. In order to protect the legitimate rights and interests of investors, the company provided additional explanations on related business conditions and issued the following risk reminders:
The IPA1299, jointly launched by the company and the participating company, Jingxinweier (Changzhou) Electronic Technology Co., Ltd. (hereinafter referred to as “Jingxinweier”) is an 8-channel low-noise design, 24-bit simultaneous sampling analog-to-digital converter chip (ADC), which is mainly used in electroencephalography (EEG), electrocardiography (ECG), and electromyography (EMG). The main feature of this product is that it can be used in the field of non-intrusive brain-computer interfaces. This product is used for high-precision measurement of human bioelectric signals. It is suitable for various wearable device application scenarios. The technical route is significantly different from the current international intrusive brain-computer interface.
As of the disclosure date of this announcement, the product is still in the market cultivation period in the field of non-intrusive brain-computer interfaces, has yet to be sold on a large scale, has not had a significant impact on the company's performance, and there is uncertainty about future sales.